Statins Good or Bad: Why the Popularity of Cholesterol-Lowering Drugs Sparks Criticism

In this episode we unpack the facts, controversies, and benefits surrounding the most prescribed drugs for lowering “bad” LDL cholesterol. Statins reduce risks of heart attack, stroke, and cardiovascular death, yet concerns over side effects - like muscle pain and blood sugar increases - fuel debates around their use. We’ll explore how statins work, the reality behind their reported side effects, and how lifestyle changes can boost their effectiveness. Join us as we dive into why statins have earned a top spot in heart health and what makes them a critical part of modern medicine. Share with a friend. Rate, Review, and Subscribe to MedEvidence Articles to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInTiktokYoutubeFor more great content, including discussions by physicians and clinical research experts, check out the MedEvidence podcast. www.MedEvidence.comThank you for listening!References:National Center for Health Statistics. (25 October, 2024). Leading causes of death. https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htmTrialists, C. T. (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61350-5/fulltextNational Center for Health Statistics. (2019). National ambulatory medical care survey: 2019 national summary tables. https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2019-namcs-web-tables-508.pdfAdhyaru, B. B., & Jacobson, T. A. (2018). Safety and efficacy of statin therapy. https://www.nature.com/articles/s41569-018-0098-5Wood et al. (2020). N-of-1 trial of a statin, placebo, or no treatment to assess side effects. https://www.nejm.org/doi/full/10.1056/NEJMc2031173Koren, M.J. & Chu, D.. (Hosts). (2024). Understanding cardiovascular wellness.  https://medevidence.com/understanding-cardiovascular-wellness-episodeDiamond, D. M., & Ravnskov, U. (2015). How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. https://www.tandfonline.com/doi/abs/10.1586/17512433.2015.1012494Jakicic et al. (2013). 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. https://www.ahajournals.org/doi/full/10.1161/01.cir.0000437740.48606.d1Koren, M. J., Hunninghake, D. B., & Alliance Investigators. (2004). Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. https://www.sciencedirect.com/science/article/pii/S0735109704016365Koren, M. J. (2005). Statin use in a “real-world” clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial https://www.sciencedirect.com/science/article/abs/pii/S0002934305007977National Heart, Lung, and Blood Institute. (19 April, 2024). Blood cholesterol causes and risk factors. National Institute of Health https://www.nhlbi.nih.gov/health/blood-cholesterol/causesStone et al. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults... https://www.ahajournals.org/doi/10.1161/01.cir.0000437738.63853.7aShare with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInTiktokYoutubeFor more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.comThank you for listening!